Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections

MP Veve, JL Wagner, RM Kenney, JL Grunwald… - International journal of …, 2016 - Elsevier
Extended-spectrum β-lactamase (ESBL) enzymes cause resistance to common β-lactam
antibiotics and are associated with poor outcomes. Management of ESBL urinary tract …
被引用次数：71 相关文章

Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.

MP Veve, JL Wagner, RM Kenney… - International Journal …, 2016 - europepmc.org
Extended-spectrum β-lactamase (ESBL) enzymes cause resistance to common β-lactam
antibiotics and are associated with poor outcomes. Management of ESBL urinary tract …

[引用][C] Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections

MP Veve, JL Wagner, RM Kenney… - International Journal of …, 2016 - cir.nii.ac.jp
Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum
β-lactamase urinary tract infections | CiNii Research CiNii 国立情報学研究所 学術情報 …

Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections

MP Veve, JL Wagner… - International …, 2016 - scholarlycommons.henryford.com
Extended-spectrum β-lactamase (ESBL) enzymes cause resistance to common β-lactam
antibiotics and are associated with poor outcomes. Management of ESBL urinary tract …

Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.

MP Veve, JL Wagner, RM Kenney, JL Grunwald… - 2016 - cabidigitallibrary.org
Extended-spectrum β-lactamase (ESBL) enzymes cause resistance to common β-lactam
antibiotics and are associated with poor outcomes. Management of ESBL urinary tract …

Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections

MP Veve, JL Wagner, RM Kenney… - International …, 2016 - pubmed.ncbi.nlm.nih.gov
Extended-spectrum β-lactamase (ESBL) enzymes cause resistance to common β-lactam
antibiotics and are associated with poor outcomes. Management of ESBL urinary tract …

Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections

MP Veve, JL Wagner, RM Kenney, JL Grunwald… - International Journal of …, 2016 - infona.pl
Extended-spectrum β-lactamase (ESBL) enzymes cause resistance to common β-lactam
antibiotics and are associated with poor outcomes. Management of ESBL urinary tract …

[引用][C] Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections

MP Veve, JL Wagner, RM Kenney, JL Grunwald… - 2016